Nanobiotix
Why Robinhood?
You can watch Nanobiotix and buy or sell other stocks, ETFs, and their options commission-free!About NBTX
Nanobiotix SA is a late-stage biotechnology company, which engages in the development of therapeutic approaches to the treatment of cancer. Its technologies include NanoXray that improves the efficacy of radiation therapy against tumor cells.
NBTX Key Statistics
NBTX News
Leerink analyst Jonathan Chang raised the firm’s price target on Nanobiotix (NBTX) to $37 from $26 and keeps an Outperform rating on the shares after the compan...
Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...
Analyst Swayampakula Ramakanth from H.C. Wainwright reiterated a Buy rating on Nanobiotix and increased the price target to €32.00 from €23.00. Unlock hedge fu...
Analyst ratings
100%
of 9 ratingsMore NBTX News
An update from Nanobiotix ( (NBTX) ) is now available. Nanobiotix announced on March 26, 2026, that it would release its fourth-quarter and full-year 2025 fina...
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.